GuidelinesOther guideline
Abbreviations
aDSM Active Drug Safety Monitoring and Management ART Antiretroviral Treatment BDQ Bedaquiline BPaL Bedaquiline, Pretomanid and Linezolid BPaLM Bedaquiline, Pretomanid, Linezolid and Moxifloxacin BPaL-L Bedaquiline, Pretomanid, Linezolid and Levofloxacin CNS Central Nervous System CFZ Clofazimine DLM Delamanid DR-TB Drug-Resistant Tuberculosis DST Drug Susceptibility Test EMB Ethambutol ECG Elect
| aDSM | Active Drug Safety Monitoring and Management |
| ART | Antiretroviral Treatment |
| BDQ | Bedaquiline |
| BPaL | Bedaquiline, Pretomanid and Linezolid |
| BPaLM | Bedaquiline, Pretomanid, Linezolid and Moxifloxacin |
| BPaL-L | Bedaquiline, Pretomanid, Linezolid and Levofloxacin |
| CNS | Central Nervous System |
| CFZ | Clofazimine |
| DLM | Delamanid |
| DR-TB | Drug-Resistant Tuberculosis |
| DST | Drug Susceptibility Test |
| EMB | Ethambutol |
| ECG | Electrocardiogram |
| EDST | Extended Drug Susceptibility Test |
| EPTB | Extra-Pulmonary Tuberculosis |
| EFV | Efavirenz |
| ETO | Ethionamide |
| FBC | Full Blood Count |
| FLQ | Fluoroquinolone |
| GXP | GeneXpert |
| HIV | Human Immunodeficiency Virus |
| HR-TB | Isoniazid resistant tuberculosis |
| INH / hdINH | Isoniazid/ high-dose Isoniazid |
| INJ | Injectable agent |
| IRIS | Immune Reconstitution Inflammatory Syndrome |
| KM | Kanamycin |
| LFX | Levofloxacin |
| LZD | Linezolid |
| MIC | Minimum Inhibitory Concentration |
| MO | Medical Officer |
| MFX | Moxifloxacin |
| MDR | Multidrug-Resistant |
| NCAC | National Clinical Advisory Committee |
| NDoH | National Department of Health |
| NIMDR | Nurse-Initiated Management of MDR TB |
| Pa | Pretomanid |
| PCAC | Provincial Clinical Advisory Committee |
| PHC | Primary Healthcare Clinic/Centre |
| PV | Pharmacovigilance |
| PVU | Pharmacovigilance Unit |
| QTc | Corrected QT interval |
| PZA | Pyrazinamide |
| RIF | Rifampicin |
| RR | Rifampicin Resistant |
| SAHPRA | South African Health Products Regulatory Authority |
| SLDs | Second-Line Tuberculosis Drugs |
| SMS | Short Message System |
| STI | Sexually Transmitted Infection |
| TB-NAAT | TB-Nucleic Acid Amplification Test |
| TRD | Terizidone |
| XDR | Extensively Drug-Resistant |
| WHO | World Health Organization |
National Department of Health Clinical Management of Rifampicin-Resistant Tuberculosis, September 2023
Abbreviations